Apellis Pharmaceuticals Inc (APLS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | APLS | KNSA | IDYA | ||
| Company | Apellis Pharmaceuticals Inc | Kiniksa Pharmaceuticals International Plc | Ideaya Biosciences Inc | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 25.08 | 42.48 | 35.76 | ||
| High | 25.08 | 42.58 | 35.76 | ||
| Low | 24.58 | 41.65 | 35.02 | ||
| Latest | 24.75 | 42.06 | 35.11 | ||
| Change | -0.41 | -0.43 | -0.57 | ||
| % Change | -1.63% | -1.01% | -1.60% | ||
| Volume | 233,291 | 76,980 | 134,598 | ||
| 20-Day Average Volume | 2,259,628 | 388,434 | 944,132 | ||
| Previous Close | 25.16 | 42.49 | 35.68 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 23.85 | 41.64 | 34.50 | ||
| 20-Day Raw Stochastic | 76.38% | 50.52% | 52.26% | ||
| 20-Day Relative Strength | 56.22 | 55.66 | 58.59 | ||
| Weighted Alpha | -7.34 | +96.20 | +63.61 | ||
| Today's Opinion | 72% Buy | 100% Buy | 100% Buy | ||
| Previous Opinion | 72% Buy | 100% Buy | 100% Buy | ||
| Last Month's Opinion | 40% Sell | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +1.29% since 12/18/25 | +0.10% since 12/18/25 | +5.77% since 12/18/25 | ||
| Low | 24.36 on 12/19/25 | 41.79 on 12/26/25 | 33.20 on 12/19/25 | ||
| High | 26.12 on 12/22/25 | 44.42 on 12/22/25 | 36.00 on 12/23/25 | ||
| 1-Month | |||||
| %Chg | +14.84% since 11/26/25 | -1.18% since 11/26/25 | -1.95% since 11/26/25 | ||
| Low | 20.51 on 12/02/25 | 39.61 on 12/03/25 | 33.10 on 12/15/25 | ||
| High | 26.12 on 12/22/25 | 44.42 on 12/22/25 | 37.08 on 12/08/25 | ||
| 3-Month | |||||
| %Chg | +10.84% since 09/26/25 | +15.21% since 09/26/25 | +31.12% since 09/26/25 | ||
| Low | 18.75 on 11/07/25 | 35.20 on 10/28/25 | 26.05 on 10/10/25 | ||
| High | 30.48 on 10/28/25 | 44.42 on 12/22/25 | 37.08 on 12/08/25 | ||
| 6-Month | |||||
| %Chg | +34.76% since 06/26/25 | +47.56% since 06/26/25 | +57.83% since 06/26/25 | ||
| Low | 17.15 on 06/30/25 | 26.27 on 07/25/25 | 20.50 on 07/01/25 | ||
| High | 30.48 on 10/28/25 | 44.42 on 12/22/25 | 37.08 on 12/08/25 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 3,183,369 | 3,220,572 | 3,127,923 | ||
| Shares Outstanding, K | 126,525 | 75,796 | 87,666 | ||
| Annual Sales | 781,370,000 | 423,240,000 | 7,000,000 | ||
| Annual Net Income | -197,880,000 | -43,190,000 | -274,480,000 | ||
| Last Quarter Sales | 458,580,000 | 180,860,000 | 207,830,000 | ||
| Last Quarter Net Income | 215,720,000 | 18,440,000 | 119,240,000 | ||
| 60-Month Beta | 0.37 | 0.02 | 0.04 | ||
| Per-Share Information | |||||
| Most Recent Earnings | 1.67 on 10/30/25 | 0.23 on 10/28/25 | 1.33 on 11/04/25 | ||
| Latest Earnings Date | 02/27/26 | 02/24/26 | 02/12/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 80.06 | 94.49 | 0.00 | ||